A world of possibilities
Navigating life sciences and medtech to the extraordinary—driven by creativity, curiosity, and the courage to build a fulfilling journey.
-
Modified Polynucleotides and LNP Compositions
Patent Number: US 10,703,789 B2Filing / Priority Date: June 12, 2019Assignees: Likely Pfizer/BioNTech collaborators (Pfizer/BioNTech use such formulations)Title: Modified polynucleotides for the production of secreted proteins What This Patent Covers This patent covers: These lipid…
-
Oral Dosing of GLP-1 Compounds
Patent: US 12,239,739 B2Filed: March 22, 2019Assignee: Novo Nordisk A/S What the Patent Covers This U.S. patent claims methods and dosing regimens for orally administering a GLP-1 peptide (such as semaglutide, the active ingredient in…
-
GIP/GLP-1 Agonist Compositions
Patent/Application: US 11357820 B2Filing Date: June 14, 2019Assignee: Eli Lilly and CompanyFamily: Part of a broader worldwide patent family covering formulations and compositions of tirzepatide and related dual agonist peptides What the Patent Covers This…
BioTech IP Review 